Extensive evidence indicates that nAChRs play a role in connection with the cognitive symptoms associated with schizophrenia and α7 nAChR has been proposed to be a potentially valuable target for the development of effective therapeutic drugs [135]. The gene discussed is CHRNA7; the disease is schizophrenia.